An article in the July 26, 2005, issue of BioWorld Today should have said that Natrecor's label was changed earlier this year to include additional data on mortality, and was not part of an official warning from the FDA. Also, the article should have said that Scios recently convened a panel of cardiologists and heart failure clinicians that suggested the company conduct several clinical trials.

Editor's note: The correction will be made in BioWorld Online.